Author:
Rezende Ribeiro Naianda,Magno Oliveira Santos Lucas,Silva Costa Scarleth,Kei Myasaki Carolina,Pagliara Lage Daniela,Tamietti Martins Vivian,Cristiane Fortes De Brito Rory,Chaves Freire Larissa,Maria Ravena Severino Carvalho Ana,Victor Serafim Brigido Bryan,José Alves Ricardo,Antonio Ferraz Coelho Eduardo,Mendes Roatt Bruno,Menezes-Souza Daniel,Costa Duarte Mariana
Funder
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
Reference57 articles.
1. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection;Abel;J. Autoimmun.,2001
2. Allen Jr, L.V.P., Nicholas G; Ansel, Howard C., 2007. Dosage forms and drug delivery systems, 8 ed.
3. Brazilian Pharmacopoeia, (Agência Nacional de Vigilância Sanitária);ANVISA/BRASIL,2012
4. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation;Aragao Horoiwa;Eur. J. Pharm. Sci.,2020
5. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran;Asilian;Bull. World Health Organ.,2003